Reducing calories may help cognitive function in MS

Published Date: 02 Mar 2023

Multiple sclerosis patients who cut calories two days a week not only lost weight but also experienced better cognition and other benefits in a new study.

Read Full News

Latest News

NfL a Biomarker for Cognitive Function in Patients With MS?

New data offer strong evidence that neurofilament light chain (NfL) levels could be an accurate biomarker for monitoring cognitive function in MS.

Most ‘Sleep-Divorced’ Couples Support Sleeping Separately

A study in Brazil reveals the prevalence and attitudes among couples not driven by relationship stress toward ‘sleep divorce’ arrangements.

Experimental Drug Cuts Migraine Days in Mid-stage Trial

Denmark's Lundbeck said on Thursday its experimental drug bocunebart cut monthly migraine days in ⁠a mid-stage study, supporting further development of a new type of...

Spinal Cord Treatment Triggers Hope and Lawsuits in Brazil

An experimental treatment for spinal cord injuries is drawing patients from as far as Mexico, mobilizing the government to expedite approval before its safety has been proven in a clinical trial.

Global Lewy Body Dementia Incidence: New Data

The first known analysis of pooled worldwide population-based data on dementia with Lewy bodies shows incidence is higher than that of other uncommon neurological disorders.

Comorbid Illness Common in Functional Neurologic Disorder

Functional neurologic disorder has a higher mortality rate than multiple sclerosis and often occurs with comorbid neurologic and psychiatric disorders, a new study shows.

Todays Updates

Simpler Screening Criteria Could Catch More Lung Cancers

A study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.

Breast Cancer Genetic Testing Need in Black Women Identified

A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.

Todays Updates

Simpler Screening Criteria Could Catch More Lung Cancers

A study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.

Breast Cancer Genetic Testing Need in Black Women Identified

A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.

Latest News

New data offer strong evidence that neurofilament light chain (NfL) levels could be an accurate biomarker for monitoring cognitive function in MS.

A study in Brazil reveals the prevalence and attitudes among couples not driven by relationship stress toward ‘sleep divorce’ arrangements.

Denmark's Lundbeck said on Thursday its experimental drug bocunebart cut monthly migraine days in ⁠a mid-stage study, supporting further development of a new type of...

An experimental treatment for spinal cord injuries is drawing patients from as far as Mexico, mobilizing the government to expedite approval before its safety has been proven in a clinical trial.

The first known analysis of pooled worldwide population-based data on dementia with Lewy bodies shows incidence is higher than that of other uncommon neurological disorders.

Functional neurologic disorder has a higher mortality rate than multiple sclerosis and often occurs with comorbid neurologic and psychiatric disorders, a new study shows.

News All Time

Roche Gets Second European Approval for Alzheimer's Test

Swiss drugmaker Roche has received the CE mark - a ⁠European regulatory clearance allowing sale in the region - for its second ⁠Elecsys blood test for Alzheimer's disease.

FDA Approves Ocrelizumab for Pediatric Relapsing MS

The FDA approval makes ocrelizumab a new treatment option for children aged 10 years and older with relapsing-remitting multiple sclerosis.

Multimodal Approach Can Manage Depression in Children

Psychotherapy is the intervention of first choice, and pharmacotherapy can be considered when psychotherapy alone is not effective, one psychiatrist says.

Decoding Spinal Muscular Atrophy (SMA): From Phenotypic Diversity to Early Diagnosis

Decoding Spinal Muscular Atrophy (SMA): From Phenotypic Diversity to Early Diagnosis

Rewriting the Code: Gene Therapy and the Future of Spinal Muscular Atrophy (SMA) Treatment

Rewriting the Code: Gene Therapy and the Future of Spinal Muscular Atrophy (SMA) Treatment

Collaborative Approaches to Detecting and Addressing Silent Disease Progression in Multiple Sclerosis

Collaborative Approaches to Detecting and Addressing Silent Disease Progression in Multiple Sclerosis

Boost Your Multifocal Motor Neuropathy (MMN) Expertise: Emerging Therapies in Focus

Boost Your Multifocal Motor Neuropathy (MMN) Expertise: Emerging Therapies in Focus

CTAD: Clinical Trials on Alzheimer's Disease Conference

The New Standard in Multiple Sclerosis: Integrating Evolving Treatment Evidence and Biomarkers to Target Progression

The New Standard in Multiple Sclerosis: Integrating Evolving Treatment Evidence and Biomarkers to Target Progression

Decoding Multifocal Motor Neuropathy: A Practical Guide to Diagnosis, Pathogenesis, and Emerging Innovations in Treatment

Decoding Multifocal Motor Neuropathy: A Practical Guide to Diagnosis, Pathogenesis, and Emerging Innovations in Treatment

CTAD Video Pearls: Video Pearls from the Clinical Trials on Alzheimer's Disease Conference

AES: American Epilepsy Society

AAN: American Academy of Neurology

ISC: International Stroke Conference

Severe Malaria in Kids Linked to Certain Cognitive, Academic Deficits Years Later

Impairment persisted after episodes of cerebral malaria or severe malarial anemia

Rat Lungworm Is Now in My State. Is It in Yours Too?

The global, brain-invading parasite continues to spread

Recommended News For You

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

Mapping lifelong chronic health risks for childhood cancer survivors

New study elucidates obesity's role in fueling breast cancer progression

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

Recommended Articles For You

Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained 

Uncovering New Hope for Follicular Lymphoma Patients 

Survival Rate Dynamics in Hematologic and Solid Malignancies 

Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Surgery may not be necessary to treat invasive breast cancer

2.

Early Results for Anorexia Nervosa with Psilocybin.

3.

A protein with new anticancer activity has been identified

4.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

5.

Chemotherapy Boosts Survival for Older Patients With TNBC

1.

Navigating the Unknown: How to Cope with Anaplastic Thyroid Cancer

2.

Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training

3.

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective

4.

Navigating the Complexities of Esophageal Cancer Staging

5.

Discovering the Benefits of TNK: A Comprehensive Blog Article 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

2.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

3.

Managing CNS diseases at the point of diagnosis in ALK + NSCLC

4.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

5.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot